Inflammatory bowel disease in children: current trends Gargi ShikhareSubra Kugathasan Review 23 April 2010 Pages: 673 - 682
Wireless capsule endoscopy in pediatric patients: the first series from Japan Daisuke TokuharaKenji WatanabeTetsuo Arakawa Original Article—Alimentary Tract 09 February 2010 Pages: 683 - 691
Reactive oxygen species-quenching and anti-apoptotic effect of polaprezinc on indomethacin-induced small intestinal epithelial cell injury Tatsushi OmatsuYuji NaitoToshikazu Yoshikawa Original Article—Alimentary Tract 20 February 2010 Pages: 692 - 702
Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening Adolfo Parra-BlancoAntonio Z. Gimeno-GarcíaJulio López-Bastida Original Article—Alimentary Tract 17 February 2010 Pages: 703 - 712
Roles of double-balloon endoscopy in the diagnosis and treatment of Crohn’s disease: a multicenter experience Jumpei KondoHideki IijimaNorio Hayashi Original Article—Alimentary Tract 20 February 2010 Pages: 713 - 720
The presence of fistulas and NOD2 homozygosity strongly predict intestinal stenosis in Crohn’s disease independent of the IL23R genotype Matthias JürgensStephan BrandThomas Ochsenkühn Original Article—Alimentary Tract 29 April 2010 Pages: 721 - 731
Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases Masanori KoyabuKazushige UchidaKazuichi Okazaki Original Article—Liver, Pancreas, and Biliary Tract 20 January 2010 Pages: 732 - 741
Adiponectin deficiency enhanced the severity of cerulein-induced chronic pancreatitis in mice Takuya YamadaHiroshi ArakiNorio Hayashi Original Article—Liver, Pancreas, and Biliary Tract 13 February 2010 Pages: 742 - 749
Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH Yuki KimuraHideyuki HyogoKazuaki Chayama Original Article—Liver, Pancreas, and Biliary Tract 30 January 2010 Pages: 750 - 757
Bezafibrate for the treatment of primary sclerosing cholangitis Suguru MizunoKenji HiranoKazuhiko Koike Original Article—Liver, Pancreas, and Biliary Tract 03 February 2010 Pages: 758 - 762
Expression of MSX2 predicts malignancy of branch duct intraductal papillary mucinous neoplasm of the pancreas Kennichi SatohShin HamadaTooru Shimosegawa Original Article—Liver, Pancreas, and Biliary Tract 28 January 2010 Pages: 763 - 770
K-ras mutation in the major duodenal papilla and gastric and colonic mucosa in patients with autoimmune pancreatitis Terumi KamisawaShin-Ichirou HoriguchiTsuneo Sasaki Original Article—Liver, Pancreas, and Biliary Tract 16 February 2010 Pages: 771 - 778
Clinical usefulness of AGEs as a biomarker for the attenuation of NASH Ilker Tasci Letter to the Editor 20 March 2010 Pages: 779 - 780
Reply to the letter by I. Tasci regarding ‘Clinical usefulness of AGEs as a biomarker for the attenuation of NASH’ Hideyuki Hyogo Letter to the Editor 24 March 2010 Pages: 781 - 781
The AGEs-RAGE axis and nonalcoholic steatohepatitis: the evidence mounts Yusuf Yilmaz Letter to the Editor 13 April 2010 Pages: 782 - 783
Reply to the letter by Y. Yilmaz regarding ‘‘the AGEs–RAGE axis and nonalcoholic steatohepatitis’’ Hideyuki Hyogo Letter to the Editor 15 April 2010 Pages: 784 - 784
